Literature DB >> 15844870

Percival Bailey and the classification of brain tumors.

Sherise Ferguson1, Maciej S Lesniak.   

Abstract

Throughout his illustrious career, Percival Bailey made numerous contributions to the fields of neurology, neuroanatomy, psychiatry, neuropathology, and, of course, neurosurgery. His expertise, his curiosity about the nervous system, and his desire to examine it from all angles were unique. With the exception of Harvey Cushing, Dr. Bailey made some of the greatest contributions in the area of neuro-oncology at the turn of the last century. In this essay the authors summarize the key episodes of Bailey's life and discuss his impact on the classification and treatment of human brain tumors.

Entities:  

Mesh:

Year:  2005        PMID: 15844870     DOI: 10.3171/foc.2005.18.4.8

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  8 in total

Review 1.  On glioblastoma and the search for a cure: where do we stand?

Authors:  John Bianco; Chiara Bastiancich; Aleksander Jankovski; Anne des Rieux; Véronique Préat; Fabienne Danhier
Journal:  Cell Mol Life Sci       Date:  2017-02-17       Impact factor: 9.261

Review 2.  The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

Authors:  Mariana Medeiros; Marina Ferreira Candido; Elvis Terci Valera; María Sol Brassesco
Journal:  Cell Mol Life Sci       Date:  2021-07-31       Impact factor: 9.261

Review 3.  Hans Joachim Scherer: an under-recognized pioneer of glioma research in Belgium.

Authors:  Gilles Reuter; Arnaud Lombard; Eric Suero Molina; Felix Scholtes; Elettra Bianchi
Journal:  Acta Neurol Belg       Date:  2021-05-17       Impact factor: 2.396

4.  Association analysis of RTEL1 variants with risk of adult gliomas in a Korean population.

Authors:  Suhg Namgoong; Hyun Sub Cheong; Jeong-Hyun Kim; Lyoung Hyo Kim; Jung Yeon Seo; Seok-Gu Kang; Seon-Jin Yoon; Se Hoon Kim; Jong Hee Chang; Hyoung Doo Shin
Journal:  PLoS One       Date:  2018-11-21       Impact factor: 3.240

Review 5.  Glioblastoma Treatment: State-of-the-Art and Future Perspectives.

Authors:  Alejandro Rodríguez-Camacho; José Guillermo Flores-Vázquez; Júlia Moscardini-Martelli; Jorge Alejandro Torres-Ríos; Alejandro Olmos-Guzmán; Cindy Sharon Ortiz-Arce; Dharely Raquel Cid-Sánchez; Samuel Rosales Pérez; Monsserrat Del Sagrario Macías-González; Laura Crystell Hernández-Sánchez; Juan Carlos Heredia-Gutiérrez; Gabriel Alejandro Contreras-Palafox; José de Jesús Emilio Suárez-Campos; Miguel Ángel Celis-López; Guillermo Axayacalt Gutiérrez-Aceves; Sergio Moreno-Jiménez
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

Review 6.  Pathology, diagnostics, and classification of medulloblastoma.

Authors:  Brent A Orr
Journal:  Brain Pathol       Date:  2020-05       Impact factor: 6.508

Review 7.  Glioblastoma: Pathogenesis and Current Status of Chemotherapy and Other Novel Treatments.

Authors:  Vilashini Rajaratnam; Mohammad Mohiminul Islam; Maixee Yang; Rachel Slaby; Hilda Martinez Ramirez; Shama Parveen Mirza
Journal:  Cancers (Basel)       Date:  2020-04-10       Impact factor: 6.639

8.  Three-Dimensional Nuclear Telomere Profiling as a Biomarker for Recurrence in Oligodendrogliomas: A Pilot Study.

Authors:  Macoura Gadji; Shubha Mathur; Brigitte Bélanger; Jaganmohan Reddy Jangamreddy; Josée Lamoureux; Ana Maria Crous Tsanaclis; David Fortin; Régen Drouin; Sabine Mai
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.